France Biochip Market Size & Outlook, 2023-2030

The biochip market in France is expected to reach a projected revenue of US$ 707.2 million by 2030. A compound annual growth rate of 12.5% is expected of France biochip market from 2024 to 2030.
Revenue, 2023 (US$M)
$311.0
Forecast, 2030 (US$M)
$707.2
CAGR, 2024 - 2030
12.5%
Report Coverage
France

France biochip market highlights

  • The France biochip market generated a revenue of USD 311.0 million in 2023 and is expected to reach USD 707.2 million by 2030.
  • The France market is expected to grow at a CAGR of 12.5% from 2024 to 2030.
  • In terms of segment, dna chips was the largest revenue generating type in 2023.
  • Lab-on-chip is the most lucrative type segment registering the fastest growth during the forecast period.


Biochip market data book summary

Market revenue in 2023USD 311.0 million
Market revenue in 2030USD 707.2 million
Growth rate12.5% (CAGR from 2023 to 2030)
Largest segmentDna chips
Fastest growing segmentLab-on-chip
Historical data2018 - 2022
Base year2023
Forecast period2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationTissue Arrays, Cell Arrays, DNA Chips, Lab-on-chip, Protein Chips
Key market players worldwideAgilent Technologies Inc, PerkinElmer, Illumina Inc, Bio-Rad Laboratories Inc, Standard BioTools Inc, GE HealthCare Technologies Inc Common Stock, Thermo Fisher Scientific Inc, Qiagen NV, Randox


Other key industry trends

  • In terms of revenue, France accounted for 2.8% of the global biochip market in 2023.
  • Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
  • In Europe, Germany biochip market is projected to lead the regional market in terms of revenue in 2030.
  • UK is the fastest growing regional market in Europe and is projected to reach USD 2,058.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Biochip Market Companies

Name Profile # Employees HQ Website

France biochip market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to biochip market will help companies and investors design strategic landscapes.


Dna chips was the largest segment with a revenue share of 38.78% in 2023. Horizon Databook has segmented the France biochip market based on tissue arrays, cell arrays, dna chips, lab-on-chip, protein chips covering the revenue growth of each sub-segment from 2018 to 2030.


France’s biochip market is projected to grow at a lucrative rate during the forecast period, owing to high cancer prevalence and the increasing burden of chronic diseases on the healthcare industry. In October 2022, the My Personal Breast Cancer Screening (MyPeBS) clinical trial was conducted in Belgium, which aimed to evaluate a breast cancer screening plan based on individual risk. 


Similarly, in June 2021, Bayer and ZERO—The End of Prostate Cancer announced the launch of a national prostate cancer education program to increase awareness about cancer screening & treatment. Such factors are expected to boost the country’s market in the coming years. 


Moreover, supportive government legislation and funding for research projects are projected to support the country’s market in the coming years. For instance, in February 2023, Agence Nationale De La Recherche made significant efforts to strengthen the role of DNA microarrays in developing novel diagnostics.

Reasons to subscribe to France biochip market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of France biochip market databook

  • Our clientele includes a mix of biochip market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of country-level data and insights on the France biochip market, including forecasts for subscribers. This country databook contains high-level insights into France biochip market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

France biochips market size, by type, 2018-2030 (US$M)

France Biochip Market Share, 2023 & 2030 (US$M)

France biochips market size, by type, 2018-2030 (US$M)

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more